-
1
Measuring Lp(a) particles with a novel isoform-insensitive immunoassay illustrates efficacy of muvalaplin
Published 2025-01-01Get full text
Article -
2
-
3
-
4
Factors Associated with Persistence with Teriparatide Therapy: Results from the DANCE Observational Study
Published 2011-01-01Get full text
Article -
5
Engineering a tumor-selective prodrug T-cell engager bispecific antibody for safer immunotherapy
Published 2024-12-01Get full text
Article -
6
-
7
Prevalence of complications and comorbidities associated with obesity: a health insurance claims analysis
Published 2025-01-01Get full text
Article -
8
Experiences and overall impact reported by people living with obesity: results from a multinational study
Published 2025-01-01Get full text
Article -
9
-
10
-
11
-
12
-
13
-
14
Anxiety-like behavior and altered hippocampal activity in a transgenic mouse model of Fabry disease
Published 2025-02-01Get full text
Article -
15
Shift from chronic to episodic migraine frequency in a long-term phase 3 study of galcanezumab
Published 2025-02-01Get full text
Article -
16
Cardiovascular Side Effects of Atomoxetine and Its Interactions with Inhibitors of the Cytochrome P450 System
Published 2011-01-01“…Atomoxetine (Strattera; Eli Lilly and Company) is a selective norepinephrine reuptake inhibitor (SNRI), one of the first medications in the nonstimulant class of medications that has been approved by the FDA for the treatment of ADHD. …”
Get full text
Article -
17
Conditional Analysis for Mixed Covariates, with Application to Feed Intake of Lactating Sows
Published 2019-01-01Get full text
Article -
18
-
19